With two potential first-in-class drug launches on the horizon, and a budding gene therapy...
Author - simom
Drug price negotiations: 5 key dates to watch
As the CMS readies its new program for lowering drug costs, these are the moments that will matter...
Tactics for growing your walled garden presence
Cultivate relationships with HCPs in gated social platforms with content that will thrive.
NICE recommends Takeda’s Ninlaro triplet regimen
Therapy involves patients living with relapsed or refractory multiple myeloma
NICE recommends PTC Therapeutics’ Translarna reimbursement
The NICE recommendation followed data from clinical trials and real-world evidence
Amvuttra recommended by NICE for amyloidosis
Therapy is among the first to receive a positive draft recommendation under streamlined pilot...
NeoPhore gains additional financing for discovery pipeline
The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies
NHS Confederation very concerned by latest industrial action
Unrelenting pressure caused by strikes, flu and COVID-19 may be keeping NHS in vicious cycle